CTI BioPharma Corp.

Historical 13F Holders

Symbol
CTIC
CUSIP
12648L601
All holders as of
Q2 2023
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2023 Q2 3 102 k $474 k
2023 Q1 144 113 M $475 M
2022 Q4 159 121 M $716 M
2022 Q3 146 99.0 M $562 M
2022 Q2 131 88.5 M $510 M
2022 Q1 106 59.6 M $345 M
2021 Q4 77 48.4 M $120 M
2021 Q3 62 54.1 M $160 M
2021 Q2 58 53.3 M $133 M
2021 Q1 62 43.3 M $126 M
2020 Q4 69 43.7 M $141 M
2020 Q3 42 39.6 M $85.1 M
2020 Q2 45 34.5 M $40.0 M
2020 Q1 41 36.6 M $33.7 M
2019 Q4 43 25.3 M $39.9 M
2019 Q3 45 25.2 M $21.0 M
2019 Q2 66 27.3 M $23.4 M
2019 Q1 74 30.6 M $29.7 M
2018 Q4 80 35.5 M $26.1 M
2018 Q3 86 35.8 M $77.4 M
2018 Q2 90 40.3 M $201 M
2018 Q1 70 36.3 M $142 M
2017 Q4 56 19.7 M $52.7 M
2017 Q3 44 18.3 M $58.4 M
2017 Q2 41 18.4 M $61.0 M
2017 Q1 49 6.73 M $28.3 M
2016 Q4 3 388 k $156 k